XPO1 and ovarian carcinoma: To investigate whether S109 is able to functionally inactivate CRM1 in ovarian cancer cells, we analyzed the subcellular localization of CRM1 cargo protein RanBP1, which is a canonical biomarker for CRM1 inhibition.